Utah Retirement Systems’s Maravai LifeSciences MRVI Stock Holding History

Utah Retirement Systems’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,800	Closed	-$205K	–	1006
2022 Q1	$205K	Hold	5,800	–	–	﹤0.01%	969
2021 Q4	$243K	Buy	5,800 +500	+9%	+$20.3K	﹤0.01%	959
2021 Q3	$260K	Buy	+5,300	New	+$259K	﹤0.01%	932

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Utah Retirement Systems's MRVI Position: Q2 2022 in Review

Utah Retirement Systems sold out of Maravai LifeSciences (MRVI) in Q2 2022, closing a stake of 5,800 shares — an estimated $205K sold.

Utah Retirement Systems first reported a position in MRVI in Q3 2021 and held it in 3 quarters. The position peaked at $260K in Q3 2021. 216 funds tracked by Wall St. Rank hold MRVI as of Q2 2022.

Utah Retirement Systems reported no remaining Maravai LifeSciences position as of Q2 2022 after selling out during the quarter.
Utah Retirement Systems sold 5,800 Maravai LifeSciences shares in Q2 2022, an estimated $205K.
Utah Retirement Systems first reported a position in Maravai LifeSciences in Q3 2021 and held it in 3 quarters.
Utah Retirement Systems's Maravai LifeSciences position peaked at $260K in Q3 2021.
216 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2022.

Based on Utah Retirement Systems's 13F filing for Q2 2022, filed 16 Aug 2022.